Skip to main content
Premium Trial:

Request an Annual Quote

Andre Hoekema, Paul Grint, Scott Kahn, Scott Greer


Galapagos Genomics said last week that it has appointed Andre Hoekema as managing director of Galadeno, the company's viral-based discovery and validation business unit.

Hoekema joins Galadeno from Invitrogen, where he was managing director of corporate development Europe. He has also held positions at Molecular Probes Europe, Crucell, DSM Life Sciences, and Genentech. He holds a PhD in physics and mathematics from Leiden University.

Illumina has appointed Paul Grint to its board of directors. Grint is currently senior vice president and chief medical officer of Zephyr Sciences, a biopharmaceutical company. He received his MD from the University of London, St. Bartholomew's Hospital Medical College.

In addition, Illumina said that Scott Kahn has been appointed Vice President and Chief Information Officer. Kahn joins Illumina from Accelrys, where he served as Chief Scientific Officer. Kahn has previously held positions with BioCAD and Molecular Simulations. He has a PhD in theoretical organic chemistry from the University of California, Irvine, and a post doc from Cambridge University, UK. He is a former assistant professor of chemistry at the University of Illinois, Urbana-Champaign.

Illumina has also announced the April 12 resignation of director Scott Greer, an Illumina director since May 2001. Greer is chairman of Abgenics.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.